Covidh Technologies Share Price & Earnings Call Analysis

₹143.90+0.00% today

Market cap: ₹354 Cr
ROE: 6.38%
Price to sales: 262.13
Debt to equity: 0.20
52W high / low: ₹151 / ₹8.14
Sales growth (5Y): -9.40%
EBITDA margin: -3.70%
Net profit margin: 20.00%
Promoter holding: 55.07%
Sales (last year): ₹1 Cr

All 10 ratios ↓

Potential multibaggers · Q2 FY27

This quarter's potential multibaggers
on management's own guidance

See all potential multibaggers Where does iSERA Lifesciences rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

1. Pick 3–15 stocks
2. Choose large, mid or small cap and your sectors
3. Get a portfolio built from the rankings

Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Financials of iSERA Lifesciences

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of iSERA Lifesciences

Quarterly Results

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.19	1.16
Expenses +	0.02	0.01	0.02	0.01	0.07	0.01	0.01	0.07	0.04	0.02	0.00	0.47	0.59
Operating Profit	-0.02	-0.01	-0.02	-0.01	-0.07	-0.01	-0.01	-0.07	-0.04	-0.02	0.00	-0.28	0.57
OPM %												-147.37%	49.14%
Other Income +	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.01	0.00	0.06
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	-0.02	-0.01	-0.02	-0.01	-0.07	-0.01	-0.01	-0.07	0.23	-0.02	0.01	-0.28	0.63
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.70%
Net Profit +	-0.02	-0.01	-0.02	-0.01	-0.07	-0.01	-0.01	-0.07	0.23	-0.02	0.01	-0.28	0.55
EPS in Rs	-0.00	-0.00	-0.00	-0.00	-0.08	-0.01	-0.01	-0.08	0.27	-0.02	0.01	-0.33	0.65

Financials of iSERA Lifesciences

Profit & Loss

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	10.90	25.50	21.36	28.92	12.30	2.13	2.13	0.00	0.00	0.00	0.00	1.36
Expenses +	10.28	25.14	20.92	28.46	11.98	2.19	0.19	0.11	0.11	0.09	0.13	1.09
Operating Profit	0.62	0.36	0.44	0.46	0.32	-0.06	1.94	-0.11	-0.11	-0.09	-0.13	0.27
OPM %	5.69%	1.41%	2.06%	1.59%	2.60%	-2.82%	91.08%					19.85%
Other Income +	0.00	-12.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.07
Interest	0.00	0.16	0.20	0.27	0.23	0.22	0.02	0.00	0.00	0.00	0.00	0.00
Depreciation	0.50	0.08	0.21	0.15	0.08	0.12	0.12	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.12	-12.49	0.03	0.04	0.01	-0.40	1.80	-0.11	-0.11	-0.09	0.14	0.34
Tax %	0.00%	0.40%	100.00%	25.00%	200.00%	5.00%	1.11%	0.00%	0.00%	0.00%	0.00%	23.53%
Net Profit +	0.12	-12.54	0.00	0.04	-0.02	-0.42	1.78	-0.11	-0.11	-0.09	0.14	0.26
EPS in Rs	0.00	-0.46	0.00	0.00	-0.00	-0.02	0.06	-0.00	-0.00	-0.11	0.17	0.31
Dividend Payout %	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials of iSERA Lifesciences

Balance Sheet

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.60	10.60	10.60	10.60	10.60	10.60	10.60	0.30	0.30	0.32	0.32	8.41
Reserves	2.44	-10.10	-10.09	-10.05	-10.07	-10.49	-10.71	-0.31	-0.42	-0.54	-0.42	-0.16
Borrowings +	4.97	6.15	6.83	7.49	7.53	6.56	2.02	0.00	0.13	0.18	1.61	1.66
Other Liabilities +	2.54	4.61	5.57	8.19	4.12	3.81	2.59	0.02	0.04	0.10	0.05	0.65
Total Liabilities	20.55	11.26	12.91	16.23	12.18	10.48	4.50	0.01	0.05	0.06	1.56	10.56
Fixed Assets +	6.65	0.48	0.44	0.45	0.75	0.62	0.43	0.00	0.00	0.00	0.00	0.00
CWIP	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	4.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets +	7.74	10.78	12.47	15.78	11.43	9.86	4.07	0.01	0.05	0.06	1.56	10.56
Total Assets	20.55	11.26	12.91	16.23	12.18	10.48	4.50	0.01	0.05	0.06	1.56	10.56

Financials of iSERA Lifesciences

Cash Flows

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	0.50	0.81	-0.63	-0.51	0.34	0.97	4.45	-0.30	-0.12	-0.06	-1.40	-5.35
Cash from Investing Activity +	-1.16	-0.40	-0.16	-0.16	-0.38	0.00	0.10	0.00	0.00	0.00	0.00	0.06
Cash from Financing Activity +	0.69	-0.42	0.77	0.66	0.04	-0.97	-4.55	0.30	0.13	0.06	1.42	8.14
Net Cash Flow	0.04	-0.01	-0.02	-0.01	0.00	0.00	-0.01	0.00	0.00	0.00	0.02	2.85
Free Cash Flow	-0.78	0.41	-0.79	-0.67	-0.04	0.97	4.55	-0.30	-0.12	-0.06	-1.40	-5.35
CFO/OP	81%	225%	-143%	-109%	112%	-1,650%	229%	273%	109%	67%	1,062%	-1,952%

Financials of iSERA Lifesciences

Ratios

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	192.55	122.81	174.64	177.96	297.34	1,470.28	498.66					322.06
Inventory Days			0.00	0.00	0.00	0.00
Days Payable
Cash Conversion Cycle	192.55	122.81	174.64	177.96	297.34	1,470.28	498.66					322.06
Working Capital Days	174.46	65.13	91.59	73.58	170.33	1,041.88	260.47					214.71
ROCE %	0.68%	2.27%	3.29%	4.03%	2.98%	-2.44%	42.42%	-11.58%			19.05%	5.95%